• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水凝胶作为潜在玻璃体替代物用于体外释放测试的流变学和物理化学优化

Rheological and physicochemical optimization of hydrogels as potential vitreous body substitutes for in vitro release testing.

作者信息

Reichel Felix, Auel Tobias, Hacker Michael C, Seidlitz Anne

机构信息

Heinrich Heine University Düsseldorf, Faculty of Mathematics and Natural Sciences, Institute of Pharmaceutics and Biopharmaceutics, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Heinrich Heine University Düsseldorf, Faculty of Mathematics and Natural Sciences, Institute of Pharmaceutics and Biopharmaceutics, Universitätsstraße 1, 40225 Düsseldorf, Germany; Freie Universität Berlin, Institute of Pharmacy, Pharmaceutical Technology, Kelchstraße 31, 12169 Berlin, Germany.

出版信息

Eur J Pharm Sci. 2025 Sep 1;212:107156. doi: 10.1016/j.ejps.2025.107156. Epub 2025 Jun 14.

DOI:10.1016/j.ejps.2025.107156
PMID:40517552
Abstract

Due to an aging society and the associated increase in age-related eye diseases of the posterior segment of the eye, an optimized in vitro vitreous model would be beneficial to assess drug release and distribution in preclinical dosage form development. A key component in such a test system is a compartment simulating the vitreous body. Several hydrogels have been proposed for this purpose. In this work the rheological properties of several vitreous body substitutes based on hyaluronic acid, hypromellose, polyacrylamide, gellan gum in combination with hyaluronic acid, and hyaluronic acid in combination with agar were investigated. By systematically comparing these potential in vitro vitreous body substitutes with porcine vitreous bodies within one study employing a series of rheological characterizations, a direct comparison was achieved, allowing opportunities for optimization to be identified. The main characterization focused on the viscosity and loss factor in the linear viscoelastic region and, for the most promising gels, also on the behavior in frequency sweeps. Additionally, the recovery times, pH values, and osmolalities of the gels were determined. Initially, phosphate-buffered saline, which served as the basis for the hydrogels, was successfully adjusted to match the pH and osmolality of porcine and human vitreous bodies. Gels made from gellan gum-hyaluronic acid and hyaluronic acid-agar proved most promising. These could be adjusted in concentrations of 0.034 % gellan gum & 0.264 % hyaluronic acid or 0.22 % hyaluronic acid & 0.09 % agar to match both the viscosity of the vitreous body and the loss factor in the linear viscoelastic region. Additionally, the pH values, osmolalities, and behavior in frequency sweeps of the gels were also comparable to the vitreous body, as these exhibit physicochemical gel formation mechanisms and reversibly linked frameworks probably similar to those of the vitreous body. Under the measurement conditions used here, the gels can therefore be considered as good in vitro vitreous body substitutes. Further diffusion studies, which will likely be influenced by the adjusted rheological properties, should be conducted in the future to further investigate the suitability of the optimized gels presented here.

摘要

由于社会老龄化以及与之相关的眼后段年龄相关性眼病的增加,优化的体外玻璃体模型将有助于在临床前剂型开发中评估药物释放和分布。这种测试系统的一个关键组件是模拟玻璃体的隔室。已经提出了几种水凝胶用于此目的。在这项工作中,研究了几种基于透明质酸、羟丙甲纤维素、聚丙烯酰胺、结冷胶与透明质酸的组合以及透明质酸与琼脂的组合的玻璃体替代物的流变学性质。通过在一项研究中使用一系列流变学表征将这些潜在的体外玻璃体替代物与猪玻璃体进行系统比较,实现了直接比较,从而确定了优化的机会。主要表征集中在线性粘弹性区域的粘度和损耗因子上,对于最有前景的凝胶,还集中在频率扫描中的行为上。此外,还测定了凝胶的恢复时间、pH值和渗透压。最初,成功调整了用作水凝胶基础的磷酸盐缓冲盐水,使其与猪和人玻璃体的pH值和渗透压相匹配。由结冷胶 - 透明质酸和透明质酸 - 琼脂制成的凝胶被证明最有前景。这些凝胶可以调整为0.034%结冷胶和0.264%透明质酸或0.22%透明质酸和0.09%琼脂的浓度,以匹配玻璃体的粘度和线性粘弹性区域的损耗因子。此外,凝胶的pH值、渗透压和频率扫描中的行为也与玻璃体相当,因为它们表现出可能与玻璃体类似的物理化学凝胶形成机制和可逆连接的框架。因此,在此处使用的测量条件下,这些凝胶可被视为良好的体外玻璃体替代物。未来应进行可能受调整后的流变学性质影响的进一步扩散研究,以进一步研究此处提出的优化凝胶的适用性。

相似文献

1
Rheological and physicochemical optimization of hydrogels as potential vitreous body substitutes for in vitro release testing.水凝胶作为潜在玻璃体替代物用于体外释放测试的流变学和物理化学优化
Eur J Pharm Sci. 2025 Sep 1;212:107156. doi: 10.1016/j.ejps.2025.107156. Epub 2025 Jun 14.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
In vivo evaluation of a Nano-enabled therapeutic vitreous substitute for the precise delivery of triamcinolone to the posterior segment of the eye.体内评估一种纳米增强型治疗性玻璃体替代物,用于精确将曲安奈德递送至眼部后节。
Drug Deliv Transl Res. 2024 Oct;14(10):2668-2694. doi: 10.1007/s13346-024-01566-1. Epub 2024 Mar 22.
4
Anterior Approach Total Ankle Arthroplasty with Patient-Specific Cut Guides.使用患者特异性截骨导向器的前路全踝关节置换术。
JBJS Essent Surg Tech. 2025 Aug 15;15(3). doi: 10.2106/JBJS.ST.23.00027. eCollection 2025 Jul-Sep.
5
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
6
Sexual Harassment and Prevention Training性骚扰与预防培训
7
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
8
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.